Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 AUD | 0.00% | -2.70% | 0.00% |
Apr. 23 | Microba's Revenue Climbs 297% in Fiscal Q3 | MT |
Apr. 10 | Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5% | MT |
Sales 2024 * | 11.81M 7.77M | Sales 2025 * | 17.97M 11.82M | Capitalization | 80.61M 53.02M |
---|---|---|---|---|---|
Net income 2024 * | -17M -11.18M | Net income 2025 * | -16M -10.52M | EV / Sales 2024 * | 5.09 x |
Net cash position 2024 * | 20.45M 13.45M | Net cash position 2025 * | 17.07M 11.23M | EV / Sales 2025 * | 3.54 x |
P/E ratio 2024 * |
-4.62
x | P/E ratio 2025 * |
-4.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 57.75% |
1 week | -2.70% | ||
Current month | -2.70% | ||
1 month | -12.20% | ||
3 months | +5.88% | ||
6 months | -21.74% |
Managers | Title | Age | Since |
---|---|---|---|
Luke Reid
CEO | Chief Executive Officer | - | - |
James Heath
DFI | Director of Finance/CFO | - | - |
Yao Liu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Capone
BRD | Director/Board Member | 61 | 21-03-17 |
Director/Board Member | - | 22-09-07 | |
Hyung-Tae Kim
BRD | Director/Board Member | 61 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 0.18 | 0.00% | 3 000 |
24-05-07 | 0.18 | 0.00% | 95 |
24-05-06 | 0.18 | 0.00% | 43,700 |
24-05-03 | 0.18 | -2.70% | 14,712 |
24-05-02 | 0.185 | 0.00% | 16,986 |
Delayed Quote Australian S.E., May 07, 2024 at 08:04 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 53.31M | |
-17.21% | 8.46B | |
+45.93% | 3.88B | |
-36.69% | 2.63B | |
-8.06% | 2.45B | |
-9.64% | 2.31B | |
-6.37% | 1.99B | |
-17.57% | 1.61B | |
-37.21% | 1.3B | |
+5.14% | 1.09B |
- Stock Market
- Equities
- MAP Stock